{"id":820937,"date":"2025-03-03T16:38:14","date_gmt":"2025-03-03T21:38:14","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/ars-pharmaceuticals-announces-conference-call-and-webcast-for-its-fourth-quarter-and-full-year-2024-financial-results-and-participation-at-upcoming-conferences\/"},"modified":"2025-03-03T16:38:14","modified_gmt":"2025-03-03T21:38:14","slug":"ars-pharmaceuticals-announces-conference-call-and-webcast-for-its-fourth-quarter-and-full-year-2024-financial-results-and-participation-at-upcoming-conferences","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/ars-pharmaceuticals-announces-conference-call-and-webcast-for-its-fourth-quarter-and-full-year-2024-financial-results-and-participation-at-upcoming-conferences\/","title":{"rendered":"ARS Pharmaceuticals Announces Conference Call and Webcast for its Fourth Quarter and Full Year 2024 Financial Results and Participation at Upcoming Conferences"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"center\">\n        <em>Company to Host Conference Call on March 20 at 8:30 a.m. ET<\/em>\n      <\/p>\n<p align=\"left\">SAN DIEGO, March  03, 2025  (GLOBE NEWSWIRE) &#8212; <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=Q5YIjE_QzxOt-xBCej6vfAv8xFHnffjB_3UTyWLpcdP00krHpYnOlmYeoAHrH6XFS5eckI3WNrT4FY578xlZp2IkHcxS92J8AoHSN6fOupY=\" rel=\"nofollow\" target=\"_blank\">ARS Pharmaceuticals, Inc.<\/a> (Nasdaq: SPRY), a biopharmaceutical company dedicated to empowering at-risk patients and caregivers to better protect themselves from allergic reactions that could lead to anaphylaxis, today announced the company will host a conference call and webcast on Thursday, March 20, 2025, at 8:30 a.m. ET to discuss its fourth quarter and full year 2024 financial results and business highlights. The dial-in information for conference participants may be obtained\u00a0by\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=3LFbK0rAT6mFUdFPkNNup0CiPBVPxr0CxRfLAtWWCWzjy-e3PFsT2uA-MYuW3TRM_KWQHDo-md6kwgn0QVVNowlQPtRKAtr1CcDrmxYHF9ECLXhYft4VNJho8OzxSLpD\" rel=\"nofollow\" target=\"_blank\">registering for the event<\/a>.<\/p>\n<p>In addition, ARS Pharma Management will be participating in several upcoming investor conferences:<\/p>\n<ul type=\"disc\">\n<li>Leerink Partners Global Healthcare Conference: fireside chat on March 10, 2025<\/li>\n<li>37<sup>th<\/sup>\u00a0Annual Roth Conference: investor meetings on March 16-18, 2025<\/li>\n<\/ul>\n<p>To access the webcast and slides, please visit the <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=JiUecb2HYLNporzoOt_KPtxJ-vt1BeVfqjT1DY5ASK3aJqr_KsHeJShXnElo05QvQsB7_9OZYYmC0RM_JSQhqH12uKqIcHcRMdz_BcOXzCcrhpKD5Y0i9AjDx3P7RIxz2o1N31mSNWv3y1YYmcXk4w==\" rel=\"nofollow\" target=\"_blank\">Events &amp; Presentations<\/a> page in the Investors &amp; Media section of the Company\u2019s <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=IW3yv4vTKZNNJVpn5GOCs7itUMIhrGeuElThnZta3h7YdbcUpqM3qEQUTDreVftSztEv1D22Ss0sPKjug7S2aw==\" rel=\"nofollow\" target=\"_blank\">website.<\/a> A replay of the webcast will be available for 30 days following the event.<\/p>\n<p>\n        <strong>About ARS Pharmaceuticals, Inc. <\/strong><br \/>\n        <br \/>ARS Pharmaceuticals is a biopharmaceutical company dedicated to empowering at-risk patients and their caregivers to better protect patients from allergic reactions that could lead to anaphylaxis. The company is commercializing <strong><em>neffy<\/em><\/strong>\u00ae 2 mg (trade name<strong> EUR<\/strong><strong><em>neffy<\/em><\/strong>\u00ae in the EU) (previously referred to as ARS-1), an epinephrine nasal spray indicated in the U.S. for emergency treatment of Type I allergic reactions, including anaphylaxis, in adult and pediatric patients who weigh 30 kg or greater, and in the EU for emergency treatment of allergic reactions (anaphylaxis) due to insect stings or bites, foods, medicinal products, other allergens, as well as idiopathic or exercise induced anaphylaxis in adults and children who weigh 30 kg or greater. For more information, visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=vzwciiIzbWzbjI_1x1fchIs3U6cGTFjCKfcwmMT0ynatDphLIgZO9l8m_4MXkpxGJ48Fi1s2k1q5PqsntkwiUkhn_c0IGy1w1f2yMviR_fY=\" rel=\"nofollow\" target=\"_blank\">www.ars-pharma.com<\/a>.<\/p>\n<p>\n        <strong>Investor Contacts:<\/strong><br \/>\n        <br \/>Justin Chakma, ARS Pharmaceuticals<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=E51OMDJXk5OBsD-nRcJt0zxo8FNTq5Giv8CSy8Y_6ykyfQi-3U-RAAJvXPA1CtbNQNrpSUcP1-yjXt-lxsF0bwDRexnlVI7uba3w1yprETaK3sMpmthzowBh4MMao-PDyvORpQnxS4CAVZJFDAnW1kmhAS-djAx1OHmmgG1hTRrE6JmUAZDmo3-glXS8nhdUaPBQJ-FNDBaV3q5BqNRJPu9legdHkbChdqgT1XuqrlQXwo2Ob-3QEzhnMpCLWTqgqtT3rLXcQBid_DtiHBXnWw==\" rel=\"nofollow\" target=\"_blank\">justinc@ars-pharma.com<\/a><\/p>\n<p>\n        <strong>Media Contact:<\/strong><br \/>\n        <br \/>Christy Curran, Sam Brown Inc.<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=LYTLdY9jQiUT-HUkMacC6onr9NJy7ZzXRxNN86gCOfxp2xodgNdsmAKhhAafA20GZZDf3-L4dPEoomt3kbc1fdWgUajGaen6m-OXGKlw1_xbtejD7jar_1OQKoSHqjJUnuII2q1CK917zRIODPxNeGCvvFxOvXaoY7wKlIgrfmJWYWKuReJpdpmzeTEAS5IqwalCJpZKNaGGnD6T8WGHBT8Pn6sMcTzICPx4V_kDWQY4rFUMkjtL27pJcV1v-Uaf586KhMmvVsMj9mpXsnuWwqMsSc7QneVCwlA4Y09IWRA=\" rel=\"nofollow\" target=\"_blank\">christycurran@sambrown.com<\/a><br \/>615.414.8668<\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM4ODE4OCM2Nzg4NTk1IzIyMDQ5Nzc=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/YjYxYzdhOTAtNjMxYS00NDQxLThmMzAtZTEzMzUwYzkwZGIxLTEyMTY1MzA=\/tiny\/ARS-Pharmaceuticals-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Company to Host Conference Call on March 20 at 8:30 a.m. ET SAN DIEGO, March 03, 2025 (GLOBE NEWSWIRE) &#8212; ARS Pharmaceuticals, Inc. (Nasdaq: SPRY), a biopharmaceutical company dedicated to empowering at-risk patients and caregivers to better protect themselves from allergic reactions that could lead to anaphylaxis, today announced the company will host a conference call and webcast on Thursday, March 20, 2025, at 8:30 a.m. ET to discuss its fourth quarter and full year 2024 financial results and business highlights. The dial-in information for conference participants may be obtained\u00a0by\u00a0registering for the event. In addition, ARS Pharma Management will be participating in several upcoming investor conferences: Leerink Partners Global Healthcare Conference: fireside chat on March 10, 2025 37th\u00a0Annual Roth Conference: &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/ars-pharmaceuticals-announces-conference-call-and-webcast-for-its-fourth-quarter-and-full-year-2024-financial-results-and-participation-at-upcoming-conferences\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;ARS Pharmaceuticals Announces Conference Call and Webcast for its Fourth Quarter and Full Year 2024 Financial Results and Participation at Upcoming Conferences&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-820937","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>ARS Pharmaceuticals Announces Conference Call and Webcast for its Fourth Quarter and Full Year 2024 Financial Results and Participation at Upcoming Conferences - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/ars-pharmaceuticals-announces-conference-call-and-webcast-for-its-fourth-quarter-and-full-year-2024-financial-results-and-participation-at-upcoming-conferences\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"ARS Pharmaceuticals Announces Conference Call and Webcast for its Fourth Quarter and Full Year 2024 Financial Results and Participation at Upcoming Conferences - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Company to Host Conference Call on March 20 at 8:30 a.m. ET SAN DIEGO, March 03, 2025 (GLOBE NEWSWIRE) &#8212; ARS Pharmaceuticals, Inc. (Nasdaq: SPRY), a biopharmaceutical company dedicated to empowering at-risk patients and caregivers to better protect themselves from allergic reactions that could lead to anaphylaxis, today announced the company will host a conference call and webcast on Thursday, March 20, 2025, at 8:30 a.m. ET to discuss its fourth quarter and full year 2024 financial results and business highlights. The dial-in information for conference participants may be obtained\u00a0by\u00a0registering for the event. In addition, ARS Pharma Management will be participating in several upcoming investor conferences: Leerink Partners Global Healthcare Conference: fireside chat on March 10, 2025 37th\u00a0Annual Roth Conference: &hellip; Continue reading &quot;ARS Pharmaceuticals Announces Conference Call and Webcast for its Fourth Quarter and Full Year 2024 Financial Results and Participation at Upcoming Conferences&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/ars-pharmaceuticals-announces-conference-call-and-webcast-for-its-fourth-quarter-and-full-year-2024-financial-results-and-participation-at-upcoming-conferences\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-03-03T21:38:14+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM4ODE4OCM2Nzg4NTk1IzIyMDQ5Nzc=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ars-pharmaceuticals-announces-conference-call-and-webcast-for-its-fourth-quarter-and-full-year-2024-financial-results-and-participation-at-upcoming-conferences\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ars-pharmaceuticals-announces-conference-call-and-webcast-for-its-fourth-quarter-and-full-year-2024-financial-results-and-participation-at-upcoming-conferences\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"ARS Pharmaceuticals Announces Conference Call and Webcast for its Fourth Quarter and Full Year 2024 Financial Results and Participation at Upcoming Conferences\",\"datePublished\":\"2025-03-03T21:38:14+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ars-pharmaceuticals-announces-conference-call-and-webcast-for-its-fourth-quarter-and-full-year-2024-financial-results-and-participation-at-upcoming-conferences\\\/\"},\"wordCount\":320,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ars-pharmaceuticals-announces-conference-call-and-webcast-for-its-fourth-quarter-and-full-year-2024-financial-results-and-participation-at-upcoming-conferences\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM4ODE4OCM2Nzg4NTk1IzIyMDQ5Nzc=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ars-pharmaceuticals-announces-conference-call-and-webcast-for-its-fourth-quarter-and-full-year-2024-financial-results-and-participation-at-upcoming-conferences\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ars-pharmaceuticals-announces-conference-call-and-webcast-for-its-fourth-quarter-and-full-year-2024-financial-results-and-participation-at-upcoming-conferences\\\/\",\"name\":\"ARS Pharmaceuticals Announces Conference Call and Webcast for its Fourth Quarter and Full Year 2024 Financial Results and Participation at Upcoming Conferences - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ars-pharmaceuticals-announces-conference-call-and-webcast-for-its-fourth-quarter-and-full-year-2024-financial-results-and-participation-at-upcoming-conferences\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ars-pharmaceuticals-announces-conference-call-and-webcast-for-its-fourth-quarter-and-full-year-2024-financial-results-and-participation-at-upcoming-conferences\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM4ODE4OCM2Nzg4NTk1IzIyMDQ5Nzc=\",\"datePublished\":\"2025-03-03T21:38:14+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ars-pharmaceuticals-announces-conference-call-and-webcast-for-its-fourth-quarter-and-full-year-2024-financial-results-and-participation-at-upcoming-conferences\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ars-pharmaceuticals-announces-conference-call-and-webcast-for-its-fourth-quarter-and-full-year-2024-financial-results-and-participation-at-upcoming-conferences\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ars-pharmaceuticals-announces-conference-call-and-webcast-for-its-fourth-quarter-and-full-year-2024-financial-results-and-participation-at-upcoming-conferences\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM4ODE4OCM2Nzg4NTk1IzIyMDQ5Nzc=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM4ODE4OCM2Nzg4NTk1IzIyMDQ5Nzc=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ars-pharmaceuticals-announces-conference-call-and-webcast-for-its-fourth-quarter-and-full-year-2024-financial-results-and-participation-at-upcoming-conferences\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"ARS Pharmaceuticals Announces Conference Call and Webcast for its Fourth Quarter and Full Year 2024 Financial Results and Participation at Upcoming Conferences\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"ARS Pharmaceuticals Announces Conference Call and Webcast for its Fourth Quarter and Full Year 2024 Financial Results and Participation at Upcoming Conferences - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/ars-pharmaceuticals-announces-conference-call-and-webcast-for-its-fourth-quarter-and-full-year-2024-financial-results-and-participation-at-upcoming-conferences\/","og_locale":"en_US","og_type":"article","og_title":"ARS Pharmaceuticals Announces Conference Call and Webcast for its Fourth Quarter and Full Year 2024 Financial Results and Participation at Upcoming Conferences - Market Newsdesk","og_description":"Company to Host Conference Call on March 20 at 8:30 a.m. ET SAN DIEGO, March 03, 2025 (GLOBE NEWSWIRE) &#8212; ARS Pharmaceuticals, Inc. (Nasdaq: SPRY), a biopharmaceutical company dedicated to empowering at-risk patients and caregivers to better protect themselves from allergic reactions that could lead to anaphylaxis, today announced the company will host a conference call and webcast on Thursday, March 20, 2025, at 8:30 a.m. ET to discuss its fourth quarter and full year 2024 financial results and business highlights. The dial-in information for conference participants may be obtained\u00a0by\u00a0registering for the event. In addition, ARS Pharma Management will be participating in several upcoming investor conferences: Leerink Partners Global Healthcare Conference: fireside chat on March 10, 2025 37th\u00a0Annual Roth Conference: &hellip; Continue reading \"ARS Pharmaceuticals Announces Conference Call and Webcast for its Fourth Quarter and Full Year 2024 Financial Results and Participation at Upcoming Conferences\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/ars-pharmaceuticals-announces-conference-call-and-webcast-for-its-fourth-quarter-and-full-year-2024-financial-results-and-participation-at-upcoming-conferences\/","og_site_name":"Market Newsdesk","article_published_time":"2025-03-03T21:38:14+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM4ODE4OCM2Nzg4NTk1IzIyMDQ5Nzc=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ars-pharmaceuticals-announces-conference-call-and-webcast-for-its-fourth-quarter-and-full-year-2024-financial-results-and-participation-at-upcoming-conferences\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ars-pharmaceuticals-announces-conference-call-and-webcast-for-its-fourth-quarter-and-full-year-2024-financial-results-and-participation-at-upcoming-conferences\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"ARS Pharmaceuticals Announces Conference Call and Webcast for its Fourth Quarter and Full Year 2024 Financial Results and Participation at Upcoming Conferences","datePublished":"2025-03-03T21:38:14+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ars-pharmaceuticals-announces-conference-call-and-webcast-for-its-fourth-quarter-and-full-year-2024-financial-results-and-participation-at-upcoming-conferences\/"},"wordCount":320,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ars-pharmaceuticals-announces-conference-call-and-webcast-for-its-fourth-quarter-and-full-year-2024-financial-results-and-participation-at-upcoming-conferences\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM4ODE4OCM2Nzg4NTk1IzIyMDQ5Nzc=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ars-pharmaceuticals-announces-conference-call-and-webcast-for-its-fourth-quarter-and-full-year-2024-financial-results-and-participation-at-upcoming-conferences\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/ars-pharmaceuticals-announces-conference-call-and-webcast-for-its-fourth-quarter-and-full-year-2024-financial-results-and-participation-at-upcoming-conferences\/","name":"ARS Pharmaceuticals Announces Conference Call and Webcast for its Fourth Quarter and Full Year 2024 Financial Results and Participation at Upcoming Conferences - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ars-pharmaceuticals-announces-conference-call-and-webcast-for-its-fourth-quarter-and-full-year-2024-financial-results-and-participation-at-upcoming-conferences\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ars-pharmaceuticals-announces-conference-call-and-webcast-for-its-fourth-quarter-and-full-year-2024-financial-results-and-participation-at-upcoming-conferences\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM4ODE4OCM2Nzg4NTk1IzIyMDQ5Nzc=","datePublished":"2025-03-03T21:38:14+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ars-pharmaceuticals-announces-conference-call-and-webcast-for-its-fourth-quarter-and-full-year-2024-financial-results-and-participation-at-upcoming-conferences\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/ars-pharmaceuticals-announces-conference-call-and-webcast-for-its-fourth-quarter-and-full-year-2024-financial-results-and-participation-at-upcoming-conferences\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ars-pharmaceuticals-announces-conference-call-and-webcast-for-its-fourth-quarter-and-full-year-2024-financial-results-and-participation-at-upcoming-conferences\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM4ODE4OCM2Nzg4NTk1IzIyMDQ5Nzc=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM4ODE4OCM2Nzg4NTk1IzIyMDQ5Nzc="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ars-pharmaceuticals-announces-conference-call-and-webcast-for-its-fourth-quarter-and-full-year-2024-financial-results-and-participation-at-upcoming-conferences\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"ARS Pharmaceuticals Announces Conference Call and Webcast for its Fourth Quarter and Full Year 2024 Financial Results and Participation at Upcoming Conferences"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/820937","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=820937"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/820937\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=820937"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=820937"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=820937"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}